FDA OKs gene-targeting skin cancer drug
* AP Wire Published:
WASHINGTON (AP) -- The Food and Drug Administration has approved a first-of-a-kind drug to treat the deadliest form of skin cancer by targeting a particular genetic mutation found in about half of patients.
The pill
sign out Welcome,
(edit)